Why is Cipla falling/rising?

Recent Price Performance and Market Context

Cipla’s share price has been under pressure over the past week, falling by 1.63%, which is notably steeper than the Sensex’s decline of 0.63% during the same period. Over the last month, the stock has marginally decreased by 0.37%, contrasting with the Sensex’s 2.27% gain. Year-to-date, Cipla’s stock is down 2.03%, while the benchmark index has advanced by 8.91%. These figures indicate that Cipla has been lagging behind the broader market indices recently, signalling some investor caution or profit-taking in the stock.

Despite this short-term underperformance, Cipla has delivered respectable returns over longer horizons. The stock has appreciated by 1.44% over the past year and posted a robust 95.70% gain over five years, outperforming the Sensex’s 86.59% in the same timeframe. This long-term growth underscores the company’s resilience and steady operational performance.

Technical Indicators and Investor Behaviour

The recent decline in Cipla’s share price is partly attributable to technical factors. The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning often signals bearish momentum and can deter short-term traders and momentum investors from entering or holding positions.

Additionally, investor participation appears to be waning. Delivery volumes, a measure of actual shares exchanged for settlement, dropped by 20.54% on 05 Dec compared to the five-day average, falling to 5.5 lakh shares. Reduced delivery volumes suggest lower conviction among investors, which can exacerbate price declines as selling pressure outweighs buying interest.

Liquidity remains adequate, with the stock’s average traded value supporting trade sizes of approximately ₹3.37 crore based on 2% of the five-day average traded value. This ensures that the stock remains accessible for institutional and retail investors alike, despite the recent dip.

Fundamental Strengths Supporting Cipla’s Valuation

While the short-term price action has been negative, Cipla’s underlying fundamentals remain robust. The company maintains a low average debt-to-equity ratio of zero, reflecting a conservative capital structure that reduces financial risk. Operating profit has grown at an annualised rate of 19.77%, signalling healthy long-term earnings momentum.

Return on equity stands at a solid 16.5%, and the stock trades at a price-to-book value of 3.7, which is considered fair relative to its historical peer valuations. Over the past year, Cipla’s profits have increased by 17.9%, outpacing the modest 1.44% rise in its share price, resulting in a price/earnings-to-growth (PEG) ratio of 1.3. This suggests the stock is reasonably valued given its earnings growth prospects.

Institutional investors hold a significant 54.8% stake in Cipla, indicating confidence from well-resourced market participants who typically conduct thorough fundamental analysis. Their continued involvement provides a stabilising influence on the stock, even amid short-term volatility.

Conclusion: Balancing Short-Term Weakness with Long-Term Potential

Cipla’s recent share price decline on 08-Dec reflects a combination of technical weakness, reduced investor participation, and broader sector trends. The stock’s fall over the past two days and its position below all major moving averages highlight short-term bearish sentiment. However, the company’s strong fundamentals, including low leverage, consistent profit growth, attractive valuation metrics, and substantial institutional backing, suggest that the current weakness may be temporary.

Investors should weigh these factors carefully. While the stock’s recent underperformance relative to the Sensex and sector peers warrants caution, Cipla’s long-term growth trajectory and financial health continue to make it a noteworthy holding within the pharmaceutical sector.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →